The Gateway to Your Orthopaedic Recovery.

Author listing

Meet our authors and contributors and explore their latest articles, insights, and expertise
Editor-in-Chief

Editor-in-Chief 's Latest Stories

Conditions : Bone Degenerative Changes; Osteoarthritis; Degenerative Disorder of Bone Interventions : Drug: Bone Morphogenetic Protein 2; Procedure: Autologous bone graft Sponsors : Northern Orthopaed...
Condition : Rheumatoid Arthritis (RA) Interventions : Other: non-interventional study; Other: non-interventional study; Other: non-interventional study; Other: non-interventional study Sponsor : Pfize...
Condition : Rheumatoid Arthritis (RA) Interventions : Other: non-interventional study; Other: non-interventional study; Other: non-interventional study; Other: non-interventional study Sponsor : Pfize...
Conditions : Acute Blood Loss Anemia; Osteoarthritis, Hip Interventions : Drug: Transexamic Acid; Drug: Placebo Sponsor : Henry Ford Health System Recruiting - verified February 2014
Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Active, not recruiting - verified February 2014
Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Recruiting - verified November 2013
Condition : Rheumatoid Arthritis Intervention : Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Recruiting - verified September 2013
Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: JNJ-38518168 (3 mg); Drug: JNJ-38518168 (10 mg); Drug: JNJ-38518168 (30 mg) Sponsors : Janssen Research & Development, LLC; Jansse...
Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: JNJ-38518168 (3 mg); Drug: JNJ-38518168 (10 mg); Drug: JNJ-38518168 (30 mg) Sponsor : Janssen Research & Development, LLC Active,...
Condition : Rheumatoid Arthritis Interventions : Drug: Placebo; Drug: JNJ-38518168 (3 mg); Drug: JNJ-38518168 (10 mg); Drug: JNJ-38518168 (30 mg) Sponsor : Janssen Research & Development, LLC Recruiti...